Procter & Gamble donates proprietary "super aspirin" technology to Vanderbilt University

NASHVILLE, TN (November 2, 2000) - The next "super aspirin" may be among a collection of 196 patents and pending patents given today to Vanderbilt University by Cincinnati-based Procter & Gamble (NYSE: PG). P&G's proprietary COX-2 Inhibitor Technology shows promise in improving the safety of medications commonly taken for pain, inflammation, and fever reduction.

Along with the patents, P&G is donating all associated intellectual property. As the sole new owners of the technology, Vanderbilt will benefit from all future revenues after the technology is further developed, tested, and commercialized.

"We are pleased that Vanderbilt's international reputation in the area of eicosanoids (COX products) has been affirmed by this generous gift of intellectual property, and we are excited with the opportunity to develop it into something of clinical value," said Lee E. Limbird, Ph.D., associate vice chancellor for Research.

Procter & Gamble's external consultants identified Vanderbilt as the university that is most uniquely qualified to further develop the COX-2 Inhibitor Technology due to their on-going leadership in COX-2 research. In addition, Vanderbilt's Office of Enterprise Development gives the framework for commercializing the technology.

"We're excited that Vanderbilt will continue to develop and test this significant technology, and that Vanderbilt will benefit both financially and academically from this donation," said P&G's Chief Technology Officer Gil Cloyd. "Best of all, we'll get to see this promising science furthered to improve peoples' lives - even if it will no longer be in P&G hands."

The gift of COX-2 Inhibitor Technology is the sixth in a series of Procter & Gamble technology donations to leading universities and research institutions.

About COX-2 inhibitor technology

COX-2 Inhibitor Technology compounds block the action of an enzyme called cyclooxygenase-2 (COX-2), and like other recently marketed COX-2 inhi

Contact: Leigh MacMillan
Vanderbilt University Medical Center

Page: 1 2 3

Related biology news :

1. Derek R. Lovley receives 2004 Proctor & Gamble Award from American Society for Microbiology
2. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
3. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
4. Dupont donates patents to UCSD
5. Donation valued at $12 million: Hoechst Research & Technology donates cut resistant fiber patents to Clemson University
6. Zengen, Inc. receives patent application approval for proprietary peptide technology
7. CWRU physicists invent "supershielding" for MRI devices
8. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
9. AACR applauds NCI initiative on nanotechnology
10. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
11. New imaging technology at Joslin shown to detect early signs of type 1 diabetes

Post Your Comments:

(Date:2/6/2020)... ... 06, 2020 , ... Kerafast Inc. , developers of ... announced an agreement with The Good Food Institute , a nonprofit organization ... partnership, terrestrial meat and aquatic cell lines will be made available to scientists ...
(Date:1/29/2020)... ... January 29, 2020 , ... ... Analytics and Data Sciences practice, providing consulting services for strategy, research and development ... by Mike Townley, co-founder and Managing Partner of CREO, an innovative management consulting ...
(Date:1/27/2020)... ... 2020 , ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), ... and Richard Castle, Global Account Manager Medical Device at PRISYM ID for ... MDR timing deadlines, best practices in creating and submitting product data and best practices ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... ... announced the release of Genedata Expressionist ® 13.5 at the 2020 ... Multi-Attribute Methods (MAM) for characterizing and monitoring the quality of biopharmaceuticals throughout ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive ... Center in New Jersey epitomize the notion that plastic surgery is much more than ... in popular media. , Over the last 20 years NJ Top Docs, Dr. Andrew ...
(Date:1/22/2020)... ... January 20, 2020 , ... ... partnership with WAVE Electronics, the largest independent electronics distributor in the US, to ... Brilliant Smart Home Systems with leading smart home products from a single fulfillment ...
(Date:1/10/2020)... ... 2020 , ... A new report from Tufts Center ... process, a critical element of clinical trial set up and execution. According to ... process creates delays in initiation in 7% of clinical trials for biopharma sponsors ...
Breaking Biology Technology:
Cached News: